Trexquant Investment’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,082
Closed -$180K 1755
2022
Q1
$180K Buy
3,082
+837
+37% +$52.4K 0.01% 1221
2021
Q4
$162K Buy
2,245
+1,385
+161% +$116K 0.01% 1186
2021
Q3
$70K Sell
860
-574
-40% -$50.3K 0.01% 1072
2021
Q2
$138K Buy
+1,434
New +$147K 0.01% 979
2021
Q1
Sell
-1,280
Closed -$167K 1361
2020
Q4
$167K Buy
+1,280
New +$165K 0.02% 925
2020
Q2
Sell
-1,145
Closed -$509K 1370
2020
Q1
$509K Buy
+1,145
New +$612K 0.04% 652

Other funds holding NXTC

Trexquant Investment's NXTC Position: Q2 2022 in Review

Trexquant Investment sold out of NextCure (NXTC) in Q2 2022, closing a stake of 3,082 shares — an estimated $180K sold.

Trexquant Investment first reported a position in NXTC in Q1 2020 and held it in 6 quarters. The position peaked at $509K in Q1 2020. 51 funds tracked by Wall St. Rank hold NXTC as of Q2 2022.

  • Trexquant Investment reported no remaining NextCure position as of Q2 2022 after selling out during the quarter.
  • Trexquant Investment sold 3,082 NextCure shares in Q2 2022, an estimated $180K.
  • Trexquant Investment first reported a position in NextCure in Q1 2020 and held it in 6 quarters.
  • Trexquant Investment's NextCure position peaked at $509K in Q1 2020.
  • 51 funds tracked by Wall St. Rank held NextCure as of Q2 2022.

Based on Trexquant Investment's 13F filing for Q2 2022, filed 11 Aug 2022.